Back to Search Start Over

Epidemiology and 3‐year outcomes of combined oral contraceptive–associated distal deep vein thrombosis

Authors :
Céline Genty
Jean-Luc Bosson
Gilles Pernod
Carole Rolland
Isabelle Quéré
Laurence Weber
Jean-Philippe Galanaud
Marie-Antoinette Sevestre
C. Richaud
Susan R. Kahn
Optimev-Sfmv investigators
Herrada, Anthony
CIC Montpellier
Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Hôpital Saint Eloi (CHRU Montpellier)
Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Sunnybrook Health Sciences Centre
University of Toronto
CHU Amiens-Picardie
CHU Grenoble
Techniques pour l'Evaluation et la Modélisation des Actions de la Santé (TIMC-IMAG-ThEMAS)
Techniques de l'Ingénierie Médicale et de la Complexité - Informatique, Mathématiques et Applications Grenoble - UMR 5525 (TIMC-IMAG)
VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes (UGA)-Institut polytechnique de Grenoble - Grenoble Institute of Technology (Grenoble INP )
Université Grenoble Alpes (UGA)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes (UGA)-Institut polytechnique de Grenoble - Grenoble Institute of Technology (Grenoble INP )
Université Grenoble Alpes (UGA)
Centre Hospitalier Henri Duffaut (Avignon)
McGill University = Université McGill [Montréal, Canada]
Jewish General Hospital
Caractéristiques féminines des dysfonctions des interfaces cardio-vasculaires (EA 2992)
Université Montpellier 1 (UM1)-Université de Montpellier (UM)
Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-CHU Saint-Eloi-Institut National de la Santé et de la Recherche Médicale (INSERM)
Source :
Research and Practice in Thrombosis and Haemostasis, Research and Practice in Thrombosis and Haemostasis, 2020, 4 (7), pp.1216-1223. ⟨10.1002/rth2.12409⟩, Research and Practice in Thrombosis and Haemostasis, Wiley, 2020, 4 (7), pp.1216-1223. ⟨10.1002/rth2.12409⟩, Research and Practice in Thrombosis and Haemostasis, Vol 4, Iss 7, Pp 1216-1223 (2020)
Publication Year :
2020
Publisher :
HAL CCSD, 2020.

Abstract

International audience; Background: Distal deep vein thrombosis (infrapopliteal DVT without proximal DVT or pulmonary embolism [PE]) generally shares the same triggering risks factors as proximal DVT. In women of childbearing age, a frequent triggering risk factor is the use of combined oral contraceptive (COC) pills. However, data on the epidemiology and long-term outcomes of COC-associated distal DVT are lacking.Objectives: To assess the epidemiology and long-term outcomes of COC-associated distal DVT.Methods: Using data from the OPTIMEV (Optimisation de l'Interrogatoire dans l'évaluation du risque thrombo-Embolique Veineux [Optimization of Interrogation in the Assessment of Thromboembolic Venous Risk]) multicenter cohort study of patients with objectively confirmed venous thromboembolism (VTE) enrolled between 2004 and 2006, we assessed in nonpregnant or postpartum women aged ≤ 50 years without cancer or history of VTE (i) proportion of COC-associated distal DVTs among women with distal DVTs and among women with COC-associated VTEs (distal DVT, proximal DVT, or PE) and (ii) 3-year incidence of death, bleeding, and VTE recurrence.Results: COC-associated distal DVTs (n = 54) represented 43.9% of all distal DVTs and 51.9% of COC-associated VTEs. All but one woman with a COC-associated distal DVT received therapeutic anticoagulation for a median of 3 months. At 3-year follow-up, all women with COC-associated distal DVTs were alive, and none had bled during anticoagulant treatment or had experienced a DVT or PE recurrence after stopping anticoagulants. Similar results were found in patients with COC-associated proximal DVT and PE: The VTE recurrence rate was 1.7% per patient-year (PY) and 0% PY, respectively, and there were no deaths or major bleeds in either group.Conclusions: Distal DVT was the most frequent clinical presentation of COC-associated VTE and had similarly favorable long-term outcomes as other COC-associated VTE.

Details

Language :
English
ISSN :
24750379
Database :
OpenAIRE
Journal :
Research and Practice in Thrombosis and Haemostasis, Research and Practice in Thrombosis and Haemostasis, 2020, 4 (7), pp.1216-1223. ⟨10.1002/rth2.12409⟩, Research and Practice in Thrombosis and Haemostasis, Wiley, 2020, 4 (7), pp.1216-1223. ⟨10.1002/rth2.12409⟩, Research and Practice in Thrombosis and Haemostasis, Vol 4, Iss 7, Pp 1216-1223 (2020)
Accession number :
edsair.doi.dedup.....95d7f0261911b2cfdb220172840d658f
Full Text :
https://doi.org/10.1002/rth2.12409⟩